Literature DB >> 25796495

Lethal 5-fluorouracil toxicity in a colorectal patient with severe dihydropyrimidine dehydrogenase (DPD) deficiency.

Carole Dhelens1,2, Agnès Bonadona3, Fabienne Thomas4,5, Claire Chapuis6, Leila Potton3, Sabrina Marsili4,5, Pierrick Bedouch6,7, Carole Schwebel3,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25796495     DOI： 10.1007/s00384-015-2191-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  4 in total

Review 1.  Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity.

Authors:  Ursula Amstutz; Tanja K Froehlich; Carlo R Largiadèr
Journal:  Pharmacogenomics       Date:  2011-09       Impact factor: 2.533

2.  Clinical relevance of different dihydropyrimidine dehydrogenase gene single nucleotide polymorphisms on 5-fluorouracil tolerance.

Authors:  Alain Morel; Michele Boisdron-Celle; Luc Fey; Patrick Soulie; Marie Claire Craipeau; Sori Traore; Erick Gamelin
Journal:  Mol Cancer Ther       Date:  2006-11       Impact factor: 6.261

Review 3.  Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil.

Authors:  André B P van Kuilenburg
Journal:  Eur J Cancer       Date:  2004-05       Impact factor: 9.162

4.  Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.

Authors:  K E Caudle; C F Thorn; T E Klein; J J Swen; H L McLeod; R B Diasio; M Schwab
Journal:  Clin Pharmacol Ther       Date:  2013-08-29       Impact factor: 6.875
  4 in total
  2 in total

1.  Reversible severe fatty liver induced by capecitabine: A case report.

Authors:  Yiyan Jiang; Qiancheng He; Suxia Li; Chang Shi; Xiaolei Yang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

Review 2.  Pharmacogenomics DNA Biomarkers in Colorectal Cancer: Current Update.

Authors:  Nurul-Syakima Ab Mutalib; Najwa F Md Yusof; Shafina-Nadiawati Abdul; Rahman Jamal
Journal:  Front Pharmacol       Date:  2017-10-12       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.